Lab equipment.
Ended Awarded
- Contract number
- HT009025FG0630076
- Awardee
-
Phadia US Inc. UEI DK4EVCWUNUM4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,960
Award facts
- Contract value 100% obligated
- $24,960.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portage, MI 49002, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded Phadia US Inc.'s Immunodiagnostics Division a $24,960.42 firm fixed-price Blanket Purchase Agreement call for laboratory equipment on June 17, 2025, with an ultimate completion date of September 30, 2025. The contract, which does not utilize a set-aside designation, will be performed in Portage, Michigan. As a foreign-owned subsidiary of Thermo Fisher Scientific, Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing sophisticated medical diagnostic technologies including immunological testing equipment, analyzers, and reagents to federal healthcare and research programs. The company has established itself as a key provider to military medical facilities through its consistent delivery of specialized diagnostic equipment and services to defense and veterans' healthcare agencies.
This contract award represents a call against Phadia US Inc.'s existing Blanket Purchase Agreement vehicle with the Defense Health Agency, enabling the procurement of immunodiagnostic equipment and related services that support military medical facilities' diagnostic capabilities. The company's extensive federal contract portfolio, including two $13.8 million single-award BPAs with Air Force Air Education and Training Command through April 2026, demonstrates its strategic importance in providing IMMUNOCAP system analyzers and allergen-specific IgE antibody testing equipment across the Department of Defense medical infrastructure. The contract continues the company's role in supplying critical laboratory diagnostic capabilities to support allergy testing and autoimmune disease management across military healthcare networks.
Quick answers
Who was awarded contract HT009025FG0630076?
HT009025FG0630076 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on June 17, 2025.
How much is contract HT009025FG0630076 worth?
The government has obligated $24,960 on HT009025FG0630076.
Is contract HT009025FG0630076 an order under another contract?
Yes. HT009025FG0630076 is a BPA call under FA301624A0046, a blanket purchase agreement.
Was contract HT009025FG0630076 competed?
The extent of competition for HT009025FG0630076 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award